WO2004037166A3 - Guanidines therapeutiques - Google Patents
Guanidines therapeutiques Download PDFInfo
- Publication number
- WO2004037166A3 WO2004037166A3 PCT/US2003/028950 US0328950W WO2004037166A3 WO 2004037166 A3 WO2004037166 A3 WO 2004037166A3 US 0328950 W US0328950 W US 0328950W WO 2004037166 A3 WO2004037166 A3 WO 2004037166A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- guanidines
- therapeutic
- ires
- infections
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003298582A AU2003298582A1 (en) | 2002-09-17 | 2003-09-16 | Therapeutic guanidines |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41159802P | 2002-09-17 | 2002-09-17 | |
US60/411,598 | 2002-09-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004037166A2 WO2004037166A2 (fr) | 2004-05-06 |
WO2004037166A3 true WO2004037166A3 (fr) | 2005-01-06 |
Family
ID=32176445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/028950 WO2004037166A2 (fr) | 2002-09-17 | 2003-09-16 | Guanidines therapeutiques |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003298582A1 (fr) |
WO (1) | WO2004037166A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
WO2007022964A2 (fr) * | 2005-08-24 | 2007-03-01 | Abbott Gmbh & Co. Kg | Composes guanidine a substitution hetaryl et utilisation en tant que partenaires de liaison pour des recepteurs de 5-ht5 |
EP2474526A3 (fr) | 2006-12-26 | 2012-07-25 | Lantheus Medical Imaging, Inc. | Ligands pour l'imagerie de l'innervation cardiaque |
AU2009282574B2 (en) | 2008-08-20 | 2014-08-21 | Merck Sharp & Dohme Corp. | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
TW201020245A (en) * | 2008-08-20 | 2010-06-01 | Schering Corp | Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
CA2734488A1 (fr) | 2008-08-20 | 2010-02-25 | Southern Research Institute | Derives de pyridine et pyrimidine substituees par azo et leur utilisation dans le traitement d'infections virales |
EP2326627A1 (fr) | 2008-08-20 | 2011-06-01 | Schering Corporation | Dérivés de pyridine et pyrimidine substituées et leur utilisation dans le traitement d'infections virales |
BR112012028806B1 (pt) | 2010-05-11 | 2021-01-19 | Lantheus Medical Imaging, Inc. | Sal ascorbato de um composto para imagiologia, seu uso para a imagiologia médica ecomposição que o compreende |
TWI700268B (zh) | 2011-09-09 | 2020-08-01 | 美商藍瑟斯醫學影像公司 | 用於合成及使用造影劑之組合物、方法及系統 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880932A (en) * | 1983-03-04 | 1989-11-14 | Bayer Aktiengesellschaft | Substituted guanidine derivatives |
-
2003
- 2003-09-16 AU AU2003298582A patent/AU2003298582A1/en not_active Abandoned
- 2003-09-16 WO PCT/US2003/028950 patent/WO2004037166A2/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880932A (en) * | 1983-03-04 | 1989-11-14 | Bayer Aktiengesellschaft | Substituted guanidine derivatives |
Also Published As
Publication number | Publication date |
---|---|
AU2003298582A8 (en) | 2004-05-13 |
WO2004037166A2 (fr) | 2004-05-06 |
AU2003298582A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003053368A3 (fr) | Derives de chalcone et leur utilisation dans le traitement de maladies | |
MXPA03005464A (es) | Agentes antivirales. | |
WO2002062290A3 (fr) | Agents antiviraux constitues de 2-methylbenzimidazole substitue heterocyclique | |
WO2008142055A3 (fr) | Agents antiviraux | |
WO2004005286A3 (fr) | Inhibiteurs viraux | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
WO1998056761A3 (fr) | Derives de benzimidazole | |
WO2003053344A3 (fr) | 2-methyl-benzimidazole substitues en tant qu'agents antiviraux du virus respiratoire syncytial | |
GB0114286D0 (en) | Nucleoside Derivatives | |
WO2003000695A8 (fr) | Pyrrolopyrimidines utilisees en tant qu'inhibiteurs des proteines kinases | |
WO2005028479A3 (fr) | Derives de purine servant a inhiber la replication du vih | |
EP2431379A3 (fr) | Inhibiteurs du VHC | |
WO2008054454A3 (fr) | Dérivés hétérocycliques contenant de l'azote, compositions pharmaceutiques, et leurs procédés d'utilisations en tant qu'agents antiviraux | |
WO2002088124A3 (fr) | Composes therapeutiques | |
WO2006011050A3 (fr) | Derives de pyridine | |
WO2001066564A3 (fr) | Inhibiteurs de gamma-sécrétase | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
NO20045042L (no) | 7-aryl -3,9-diazabicyklo (3.1.1)non-6-en-derivater og deres anvendelse som renin. inhibitorer ved behandling av hypertensjon, kardiovaskulaere og nyresykdommer | |
WO2003053359A3 (fr) | 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections | |
WO2003047520A3 (fr) | Inhibiteurs de facteur xa a aminomethyle substitue | |
MXPA03010761A (es) | Combinaciones farmaceuticas. | |
WO2004043362A3 (fr) | Composes d'acyl guanidine et utilisation | |
WO2007075572A3 (fr) | Inhibiteurs a base de purine oralement actifs de la proteine de choc thermique 90 | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
WO2004037166A3 (fr) | Guanidines therapeutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |